Spots Global Cancer Trial Database for italy
Every month we try and update this database with for italy cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera | NCT05548062 | Polycythemia Ve... | Hydroxyurea Ruxolitinib | 18 Years - 99 Years | Novartis | |
Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera | NCT05548062 | Polycythemia Ve... | Hydroxyurea Ruxolitinib | 18 Years - 99 Years | Novartis | |
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy | NCT05376579 | Active Secondar... | siponimod | 18 Years - 60 Years | Novartis | |
Facilitate the Return to Work of Cancer Survivors | NCT03666936 | Neoplasms Return to Work | Social-health c... | - | Arcispedale Santa Maria Nuova-IRCCS | |
Facilitate the Return to Work of Cancer Survivors | NCT03666936 | Neoplasms Return to Work | Social-health c... | - | Arcispedale Santa Maria Nuova-IRCCS | |
Impact of Mayzent on aSPMS Patients in a Long-term NIS in Italy | NCT05376579 | Active Secondar... | siponimod | 18 Years - 60 Years | Novartis |